Naturally Splendid (TSXV:NSP,FWB:50N,OTCQB:NSPDF) has received an initial purchase order for its hemp food products from Korea Beauty & Health Care Co., in South Korea. The first 20 tonne shipment of hulled hemp seeds will leave Naturally Splendid’s Burnaby distribution center on February 5 2016.
As quoted in the press release:

Korea Beauty & Health Care Co., Ltd. (KBH) was established in 2003 and has a successful track record bringing a variety of products to the South Korean marketplace in the area of cosmetics, household items, functional foods, and medical equipment. KBH was certified as a food manufacturer and cosmetic manufacturer in 2015 and is also a product developer with its own R&D facility. The Company currently employs 62 people and generated revenue of approximately 12,000,000,000 Won ($14,000,000 CDN) in 2015 via online shopping, offline shopping, traditional retail and TV shopping channels. KBH will be marketing the NATERA(R) brand through online shopping, offline shopping, traditional retail and TV shopping channels.


Naturally Splendid CEO, Craig Goodwin, said:

This initial order is secured by an irrevocable letter of credit which is a recognized financial instrument for international business. All in all, this is a significant day in the development of Naturally Splendid. As I’ve stated on several occasions, much of 2015 was focused on acquiring technology and processing capacity as well as the personnel to execute our vision. I believe that 2016 will be the year when our efforts will be translated into multiple revenue streams. The South Korean opportunity secures us a foothold in the growing Asian market. We see increased interest for our hemp food products in Asia and we are in advanced discussions with several other groups in Asia and anticipate additional purchase orders from the region in due course.

Connect with Naturally Splendid (TSXV:NSP,FWB:50N,OTCQB:NSPDF) to receive an Investor Presentation.

Two US-based multi-state operators (MSOs) added fuel to the ongoing merger and acquisition (M&A) train currently making its way across the cannabis sector.

On the flip side, one of Canada’s biggest cannabis producers told the market this week that it has no interest in further acquisitions in the Canadian market.

Keep reading... Show less

 Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”), a wellness company that makes and sells plant-based products, is ramping up production at its Victoria, BC production facility to fulfill incoming orders from seven Whole Foods Market in Ontario, Canada (“Whole Foods”).

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/84022_947985ee845d7afb_001.jpg

Keep reading... Show less
  • Domestic Medical Net Revenue Steady at $26.9 Million
  • Strong International Medical Net Revenue of $9.4 Million
  • Total Cannabis Net Revenue, Excluding Provisions, of $58.4 Million
  • Business Transformation Plan Continues, Management Expects to Deliver Incremental Cost-Saving Measures of $60 Million to $80 Million Annually
  • Balance Sheet Remains Strong with ~$525 Million of Cash on Hand at May 12, 2021
  • Lead Independent Director Ronald Funk Appointed as Chairman, Michael Singer to Remain Board Member

NYSE | TSX: ACB

 Aurora Cannabis Inc. (the ” Company ” or ” Aurora “) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the third quarter of fiscal 2021 ended March 31, 2021 .

Keep reading... Show less

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies

Keep reading... Show less

Experienced executives fill senior roles in business development, M&A, clinic operations and design, and corporate communications

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced the appointments of five experienced leaders to support strategic growth initiatives across the Company’s three divisions Numinus Health, Numinus R&D and Numinus Bioscience.

Keep reading... Show less